(Q54052663)

24 May 2018

title

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection. (English)

1 reference

24 May 2018

0 references

4

Colson P

1 reference

24 May 2018

Tamalet C

1

1 reference

24 May 2018

Pasquier C

2

1 reference

24 May 2018

Yahi N

3

1 reference

24 May 2018

Poizot-Martin I

5

1 reference

24 May 2018

Lepeu G

6

1 reference

24 May 2018

Gallais H

7

1 reference

24 May 2018

Massip P

8

1 reference

24 May 2018

Puel J

9

1 reference

24 May 2018

Izopet J

10

1 reference

24 May 2018

publication date

1 June 2000

1 reference

24 May 2018

Journal of Medical Virology

published in

1 reference

24 May 2018

volume

61

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

181-186

1 reference

24 May 2018

HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Time to hit HIV, early and hard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Caution: should we be treating HIV infection early?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Stable rearrangements of the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase in plasma viruses from patients receiving combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Impact of drug resistance mutations on virologic response to salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

The era of adherence to HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Progress and problems in the fight against AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Hepatotoxicity after introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

Detection of low HIV-1 RNA levels in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28200006%2961%3A2%3C181%3A%3AAID-JMV2%3E3.0.CO%3B2-T

10.1002/(SICI)1096-9071(200006)61:2<181::AID-JMV2>3.0.CO;2-T

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018